ResMed Inc.
RSMDF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $40,094 | $37,790 | $32,843 | $33,586 |
| - Cash | $1,384 | $1,209 | $933 | $522 |
| + Debt | $846 | $852 | $840 | $840 |
| Enterprise Value | $39,556 | $37,432 | $32,750 | $33,903 |
| Revenue | $1,336 | $1,348 | $1,292 | $1,282 |
| % Growth | -0.9% | 4.4% | 0.8% | – |
| Gross Profit | $821 | $820 | $766 | $751 |
| % Margin | 61.5% | 60.8% | 59.3% | 58.6% |
| EBITDA | $503 | $532 | $470 | $479 |
| % Margin | 37.7% | 39.5% | 36.4% | 37.4% |
| Net Income | $349 | $380 | $365 | $345 |
| % Margin | 26.1% | 28.2% | 28.3% | 26.9% |
| EPS Diluted | 2.37 | 2.58 | 2.48 | 2.34 |
| % Growth | -8.1% | 4% | 6% | – |
| Operating Cash Flow | $457 | $539 | $579 | $309 |
| Capital Expenditures | -$43 | -$31 | -$24 | -$19 |
| Free Cash Flow | $414 | $508 | $555 | $290 |